Bouchard brought this up during today's C-call. The information below is detailed in the 10-Q:
Corporate and Other also includes the results of Cosmedicine, a smaller specialty cosmetics business owned by the Company, as it does not meet the threshold of a reportable segment. For the three and six months ended June 30, 2015, operating costs in Corporate and Other were $4.1 million and $7.3 million, respectively. The operations of Cosmedicine, which re-launched its branded skin care product line during the second quarter, generated losses of $0.4 million and $0.7 million, respectively, in the three and six months ended June 30, 2015, and are included in the results of operations of Corporate and Other.